Page 101 - 《中国药房》2023年24期

2010，24（Suppl 1）：25-27. 194：128-135.e1.
[18] SATAPATHY S K，ISABEL FIEL M，DEL RIO MARTIN [30] BECKER H，WILLEKE P，DOMSCHKE W，et al. Etaner‐
J，et al. Hemophagocytic syndrome occurring in an adult cept tolerance in a patient with previous infliximab-
liver transplant recipient having Still’s disease[J]. Hepatol induced hepatitis[J]. Clin Rheumatol，2008，27（12）：1597-
Int，2010，5（1）：597-602. 1598.
[19] GOLDFELD D A，VERNA E C，LEFKOWITCH J，et al. [31] ADAR T，MIZRAHI M，PAPPO O，et al. Adalimumab-
Infliximab-induced autoimmune hepatitis with successful induced autoimmune hepatitis[J]. J Clin Gastroenterol，
switch to adalimumab in a patient with Crohn’s disease： 2010，44（1）：e20-e22.
the index case[J]. Dig Dis Sci，2011，56（11）：3386-3388. [32] GRASLAND A，STERPU R，BOUSSOUKAYA S，et al.
[20] SUBRAMANIAM K，CHITTURI S，BROWN M，et al. Autoimmune hepatitis induced by adalimumab with suc‐
Infliximab-induced autoimmune hepatitis in Crohn’s cessful switch to abatacept[J]. Eur J Clin Pharmacol，
disease treated with budesonide and mycophenolate[J]. 2012，68（5）：895-898.
Inflamm Bowel Dis，2011，17（11）：E149-E150. [33] MIRANDA-BAUTISTA J，MENCHÉN L. Adalimumab-
[21] VAN CASTEREN-MESSIDORO C，PRINS G，VAN induced autoimmune hepatitis in a patient with Crohn’s
TILBURG A，et al. Autoimmune hepatitis following treat‐ disease[J]. Gastroenterol Hepatol，2019，42（5）：306-307.
ment with infliximab for inflammatory bowel disease[J]. J [34] PETRÍKOVÁ J，JARČUŠKA P，SVAJDLER M，et al. Au‐
Crohns Colitis，2012，6（5）：630-631. toimmune hepatitis triggered by adalimumab and allergic
[22] DANG L J，LUBEL J S，GUNATHEESAN S，et al. Drug- reactions after various anti-TNFα therapy agents in a pa‐
induced lupus and autoimmune hepatitis secondary to in- tient with rheumatoid arthritis[J]. Isr Med Assoc J，2015，
fliximab for psoriasis[J]. Australas J Dermatol，2014，55 17（4）：256-258.
（1）：75-79. [35] NAKAYAMA S. Autoimmune hepatitis triggered by anti-
[23] MOSTAMAND S，SCHROEDER S，SCHENKEIN J，et TNF-α therapy[J]. Case Rep Med，2013，2013：561748.
al. Infliximab-associated immunomediated hepatitis in [36] HARADA K，AKAI Y，KOYAMA S，et al. A case of au-
children with inflammatory bowel disease[J]. J Pediatr toimmune hepatitis exacerbated by the administration of
Gastroenterol Nutr，2016，63（1）：94-97. etanercept in the patient with rheumatoid arthritis[J]. Clin
[24] ARAI O，OMOTO K，NOTOHARA K，et al. A case of Rheumatol，2008，27（8）：1063-1066.
infliximab-related liver damage-case report and literature [37] FATHALLA B M，GOLDSMITH D P，PASCASIO J M，
review[J]. Jpn J Gastro Enterol，2013，110（1）：104-111. et al. Development of autoimmune hepatitis in a child
[25] COLINA F，MOLERO A，CASÍS B，et al. Infliximab- with systemic-onset juvenile idiopathic arthritis during
related hepatitis：a case study and literature review[J]. Dig therapy with etanercept[J]. J Clin Rheumatol，2008，14
Dis Sci，2013，58（11）：3362-3367. （5）：297-298.
[26] KARANFILIAN B，MAHPOUR N，SARKAR A. Infli- [38] VOLLMER O，FELTEN R，MERTZ P，et al. Characteriza‐
ximab drug-induced autoimmune hepatitis in a patient tion of auto-immune hepatitis associated with the use of
with Crohn’s ileocolitis[J]. Am J Ther，2022，29（6）：e741- anti-TNFα agents：an analysis of 389 cases in VigiBase[J].
e743. Autoimmun Rev，2020，19（3）：102460.
[27] WONG F，IBRAHIM B A，WALSH J，et al. Infliximab- [39] SCHWINGE D，SCHRAMM C. Sex-related factors in au‐
induced autoimmune hepatitis requiring liver transplan- toimmune liver diseases[J]. Semin Immunopathol，2019，
tation[J]. Clin Case Rep，2019，7（11）：2135-2139. 41（2）：165-175.
[28] YILMAZ B，ROACH E C，KOKLU S. Infliximab leading [40] THOMAS D，WU T Y，COTTAGIRI M，et al. Induction
to autoimmune hepatitis：an increasingly recognized side of drug-induced，autoimmune hepatitis in BALB/c mice
effect[J]. Dig Dis Sci，2014，59（10）：2602-2603. for the study of its pathogenic mechanisms[J]. J Vis Exp，
[29] RICCIUTO A，KAMATH B M，WALTERS T D，et al. 2020：159.
New onset autoimmune hepatitis during anti-tumor necro‐ （收稿日期：2023-06-26 修回日期：2023-11-18）
sis factor-alpha treatment in children[J]. J Pediatr，2018， （编辑：陈 宏）

中国药房 2023年第34卷第24期 China Pharmacy 2023 Vol. 34 No. 24 · 3035 ·